Welcome to our dedicated page for Acm Research SEC filings (Ticker: ACMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ACM Research’s wafer-cleaning and advanced-packaging systems sit at the heart of today’s most intricate chip fabs—yet the disclosures that explain how those tools drive revenue and margins stretch well past 200 pages. Finding segment sales to Chinese foundries, understanding megasonic R&D spend, or monitoring insider sales after export-control headlines can feel overwhelming. That’s why investors searching for “ACM Research SEC filings explained simply” start here.
Stock Titan applies AI-powered parsing to every document the moment it hits EDGAR. Whether you need the full ACM Research quarterly earnings report 10-Q filing, a line-by-line breakdown of the ACM Research annual report 10-K simplified, or ACM Research 8-K material events explained, our platform converts technical language into concise, decision-ready insights. Real-time alerts surface ACM Research Form 4 insider transactions, while side-by-side charts compare backlog, gross margin and regional revenue across periods—saving hours of manual cross-referencing.
Use cases are practical: track ACM Research executive stock transactions Form 4 before earnings, study wafer-cleaning tool demand swings through our ACM Research earnings report filing analysis, or verify board pay packages in the ACM Research proxy statement executive compensation section. All filing types—10-K, 10-Q, 8-K, S-8, Form 4—are covered with comprehensive, time-stamped updates. From megasonic-cleaning capacity additions to advanced-packaging revenue outlook, understanding ACM Research SEC documents with AI has never been easier.
Tracy Liu, a director of ACM Research, Inc. (ACMR), reported acquiring derivative securities on 08/12/2025. The Form 4 shows an option (exercise price $24.93) to acquire 20,000 shares of Class A common stock, recorded as an acquisition on 08/12/2025 and resulting in beneficial ownership of 20,000 shares. The option "will vest and become exercisable immediately prior to the 2026 annual meeting of stockholders," subject to continued service through the vesting date. The filing was submitted by one reporting person and signed on behalf of Ms. Liu by attorney-in-fact Mark McKechnie on 08/14/2025.
Haiping Dun, a director of ACM Research, Inc. (ACMR), reported acquiring a derivative security on 08/12/2025. The Form 4 shows an acquisition of a stock option covering 20,000 shares of Class A common stock with an exercise price of $24.93 and an expiration date of 08/11/2035. Following the reported transaction, the filing lists 20,000 shares beneficially owned directly by the reporting person.
The filing explains the option "will vest and become exercisable immediately prior to the 2026 annual meeting of stockholders," subject to continued service through the vesting date. The Form 4 was signed by an attorney-in-fact on behalf of Haiping Dun on 08/14/2025.
ACM Research (ACMR) filed a Form 4 reporting that subsidiary CFO Lisa Feng exercised 15,000 stock options at $5.60 and immediately sold the same number of Class A shares at $26.00 on 06/24/2025 under a Rule 10b5-1 plan. Cash proceeds totaled roughly $390 k; her beneficial ownership remains 50,001 shares, indicating no net change in holdings.
FAQ
What is the current stock price of Acm Research (ACMR)?
What is the market cap of Acm Research (ACMR)?
